Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 16/20 | 0.59 |
| ▸ | CA1 | P00915 | 16/20 | 0.59 |
| ▸ | CA2 | P00918 | 16/20 | 0.59 |
| ▸ | CA9 | Q16790 | 16/20 | 0.59 |
| ▸ | PRKCA | P17252 | 1/20 | 0.56 |
| ▸ | AKT1 | P31749 | 1/20 | 0.56 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 12/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.45 |
| ▸ | FYN | P06241 | 1/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.45 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.45 |
| ▸ | DRD4 | P21917 | 1/20 | 0.45 |
| ▸ | DRD3 | P35462 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8670693 | 0.91 | CA12 (0.60) | CA12CA1CA2CA9PRKCA | |
| SCHEMBL9735191 | 0.89 | CA1 (0.49) | CA12CA1CA2CA9PRKCA | |
| SCHEMBL9524271 | 0.89 | CA1 (0.49) | CA12CA1CA2CA9PRKCA | |
| SCHEMBL13707322 | 0.88 | PRKCA (0.56) | CA12CA1CA2CA9PRKCA | |
| SCHEMBL16009180 | 0.87 | CA12 (0.64) | CA12CA1CA2CA9PRKCA | |
| SCHEMBL13480230 | 0.87 | PRKCA (0.55) | CA12CA1CA2CA9PRKCA | |
| SCHEMBL13480540 | 0.87 | PRKCA (0.55) | CA12CA1CA2CA9PRKCA | |
| SCHEMBL2926711 | 0.87 | PRKCA (0.55) | CA12CA1CA2CA9PRKCA | |
| SCHEMBL13904009 | 0.87 | PRKCA (0.55) | CA12CA1CA2CA9PRKCA | |
| SCHEMBL9343530 | 0.87 | PRKCA (0.55) | CA12CA1CA2CA9PRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9085598-B2 | Compounds targeting the cell invasion protein complex, their pharmaceutical compositions and methods of use thereof | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) | 2015-07-21 | — | — | US | disclosed |
| US-20140256659-A1 | Compounds Targeting the Cell Invasion Protein Complex, Their Pharmaceutical Compositions and Methods of Use Thereof | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) | 2014-09-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140256659-A1 | Compounds Targeting the Cell Invasion Protein Complex, Their Pharmaceutical Compositions and Methods of Use Thereof | PTK2, ILK, CTTN | CA12 2331/4885CA1 1861/4885CA2 1652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.